This antibody binds S-protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The J08 is able to potently neutralize most variants of concern (VoCs) and independent of known escape mutations. It binds high on the receptor binding domain (RBD) ridge and has low nanomolar affinity against most VoCs, which was evaluated using cell-based assays.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
VS-0923-XY23 | Recombinant Human Anti-SARS-CoV-2 S1 Antibody (clone CS124) | ELISA, SPR, BLI, Neut | Human IgM |
VS-0923-XY25 | Recombinant Human Anti-SARS-CoV-2 S1 Antibody (clone 002-S21F2) | ELISA, BLI, Neut | Human IgG |
VS-0923-XY26 | Recombinant Mouse Anti-SARS-CoV-2 S1 Antibody (clone 17B10) | ELISA, BLI, Neut | Mouse IgG1 |
VS-0923-XY27 | Recombinant Mouse Anti-SARS-CoV-2 S1 Antibody (clone 8H12) | ELISA, SPR, Neut | Mouse IgG |
VS-0224-XY110 | Human Anti-SARS-CoV-2 S1 Recombinant Antibody (clone AM130) | ELISA | Human IgA1, kappa |
There are currently no Customer reviews or questions for VS-0723-XY9. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.